Abstract

Clinical trials are the backbone for advancing therapeutic options for patients diagnosed with cancer. Yet only 7.1% of patients with cancer participate in clinical trials in the United States. In this article, we review some of the reasons for poor accrual and discuss potential solutions.

Original languageEnglish
Pages (from-to)3655-3657
Number of pages3
JournalClinical Cancer Research
Volume30
Issue number17
DOIs
StatePublished - Sep 1 2024

Fingerprint

Dive into the research topics of 'Novel Therapies in Cancer: Trials and Tribulations'. Together they form a unique fingerprint.

Cite this